Is Post-SSRI Sexual Dysfunction real and does it have anything to do with Post-Finasteride Syndrome?

Linked videos:
   • Post Finasteride Syndrome  
   • Finasteride does NOT cause depression or s...  
   • Does finasteride cause suicide?  
   • 2.5 MG of dutasteride is the ultimate hair...  
   • What to do if you get side effects from fi...  
   • Vioxx and finasteride, how frivolous lawsu...  
   • Post-finasteride syndrome and post-accutan...  
   • Post-Finasteride Syndrome is a myth  

Selected sources:
1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61. doi:10.1016/s0022-5347(17)34871-1
2. Stoffel-Wagner B. Neurosteroid metabolism in the human brain. European Journal of Endocrinology. 2001;145(6):669-679. doi:10.1530/eje.0.1450669
3. Karlsson T, Vahlquist A, Kedishvili N, Törmä H. 13-cis-Retinoic acid competitively inhibits 3α-hydroxysteroid oxidation by retinol dehydrogenase RoDH-4: a mechanism for its anti-androgenic effects in sebaceous glands? Biochemical and Biophysical Research Communications. 2003;303(1):273-278. doi:10.1016/S0006-291X(03)00332-2
4. Wessells H, Roy J, Bannow J, et al. Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia. Urology. 2003;61(3):579-584. doi:10.1016/S0090-4295(02)02401-9
5. Hull EM, Muschamp JW, Sato S. Dopamine and serotonin: influences on male sexual behavior. Physiol Behav. 2004;83(2):291-307. doi:10.1016/j.physbeh.2004.08.018
6. Karadeniz T, Topsakal M, Aydogmus A, Basak D. Erectile Dysfunction Under Age 40: Etiology and Role of Contributing Factors. The Scientific World JOURNAL. 2004;4:171-174. doi:10.1100/tsw.2004.64
7. Finn DA, Beadles‐Bohling AS, Beckley EH, et al. A New Look at the 5α‐Reductase Inhibitor Finasteride. CNS Drug Rev. 2006;12(1):53-76. doi:10.1111/j.1527-3458.2006.00053.x
8. Pompili M, Serafini G, Innamorati M, et al. Antidepressants and Suicide Risk: A Comprehensive Overview. Pharmaceuticals (Basel). 2010;3(9):2861-2883. doi:10.3390/ph3092861
9. McMahon CG. Dapoxetine: a new option in the medical management of premature ejaculation. Ther Adv Urol. 2012;4(5):233-251. doi:10.1177/1756287212453866
10. Mysore V. Finasteride and sexual side effects. Indian Dermatol Online J. 2012;3(1):62-65. doi:10.4103/2229-5178.93496
11. Jing E, Straw-Wilson K. Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review. Ment Health Clin. 2016;6(4):191-196. doi:10.9740/mhc.2016.07.191
12. Martinez PE, Rubinow DR, Nieman LK, et al. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder. Neuropsychopharmacology. 2016;41(4):1093-1102. doi:10.1038/npp.2015.246
13. Bala A, Nguyen HMT, Hellstrom WJG. Post-SSRI Sexual Dysfunction: A Literature Review. Sexual Medicine Reviews. 2018;6(1):29-34. doi:10.1016/j.sxmr.2017.07.002
14. Giatti S, Diviccaro S, Panzica G, Melcangi RC. Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin? Endocrine. 2018;61(2):180-193. doi:10.1007/s12020-018-1593-5
15. Healy D. Antidepressants and sexual dysfunction: a history. J R Soc Med. 2020;113(4):133-135. doi:10.1177/0141076819899299
16. Azizi A, Mumin NH, Shafqat N. Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment. F1000Res. 2021;10:221. doi:10.12688/f1000research.51066.3
17. Lagerberg T, Fazel S, Sjölander A, Hellner C, Lichtenstein P, Chang Z. Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study. Neuropsychopharmacol. 2022;47(4):817-823. doi:10.1038/s41386-021-01179-z
18. Peleg LC, Rabinovitch D, Lavie Y, et al. Post-SSRI Sexual Dysfunction (PSSD): Biological Plausibility, Symptoms, Diagnosis, and Presumed Risk Factors. Sexual Medicine Reviews. 2022;10(1):91-98. doi:10.1016/j.sxmr.2021.07.001
19. Ben-Sheetrit J, Hermon Y, Birkenfeld S, Gutman Y, Csoka A, Toren P. Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants. Annals of General Psychiatry. 2023;22. doi:10.1186/s12991-023-00447-0
20. Laanani M, Weill A, Jollant F, Zureik M, Dray-Spira R. Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study. Sci Rep. 2023;13(1):5308. doi:10.1038/s41598-023-32356-3
21. Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood–brain barrier: structure, regulation, and drug delivery. Sig Transduct Target Ther. 2023;8(1):1-27. doi:10.1038/s41392-023-01481-w
22. Giatti S, Diviccaro S, Cioffi L, Cosimo Melcangi R. Post-Finasteride Syndrome And Post-Ssri Sexual Dysfunction: Two Clinical Conditions Apparently Distant, But Very Close. Frontiers in Neuroendocrinology. 2024;72:101114. doi:10.1016/j.yfrne.2023.101114